Pfizer (PFE) Buildings (2009 - 2013)

Pfizer has disclosed Buildings across 5 years of filings, most recently posting $10.1 billion for Q4 2013.

• In Q4 2013, Buildings fell 5.52% year-over-year to $10.1 billion; the TTM figure through Dec 2013 stood at $10.1 billion (down 5.52% YoY), while the FY2013 annual figure was $10.1 billion, down 5.52% from the prior year.
• Buildings slipped to $10.1 billion in Q4 2013, from $10.6 billion in the prior quarter.
• Over the last five years, Buildings for PFE reached as high as $14.2 billion in Q4 2009 and fell as low as $10.1 billion in Q4 2013.
• The 5-year median for Buildings is $12.1 billion (2011), against an average of $12.0 billion.
• Annual changes were most pronounced in 2012 — Buildings fell 11.96% — and 2013, when it retreated 5.52%.
• A 5-year view of Buildings shows it stood at $14.2 billion in 2009, then fell by 6.95% to $13.2 billion in 2010, then slipped by 8.42% to $12.1 billion in 2011, then slipped by 11.96% to $10.6 billion in 2012, then declined by 5.52% to $10.1 billion in 2013.
• According to Business Quant data, Buildings over the past three periods registered $10.1 billion, $10.6 billion, and $12.1 billion for Q4 2013, Q4 2012, and Q4 2011 respectively.